comparemela.com

சாவை மருந்து இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®

Press release content from Business Wire. The AP news staff was not involved in its creation. Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion® January 28, 2021 GMT TAMPA, Fla. (BUSINESS WIRE) Jan 28, 2021 Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and marketing of Relivion ®, a non-invasive digital medical device for migraine and depression, in Japan. ADVERTISEMENT (Photo: Business Wire) Relivion ® is a non-invasive brain neuromodulation device that is placed around the head and delivers unparalleled stimulation to the occipital and trigeminal nerves. This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is designed to allow patients to use Relivion ® at home, and share treatment data with their physic

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.